Roflumilast (Daliresp) for chronic obstructive pulmonary disease

2014 
Roflumilast therapy has a limited role in patients with severe COPD, and no role in patients with mild to moderate COPD. It will not decrease the number of hospitalizations.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    3
    References
    1
    Citations
    NaN
    KQI
    []